• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Intraocular Pressure Decrease Does Not Affect Blood Flow Rate of Ophthalmic Artery in Ocular Hypertension.眼压降低不会影响高眼压症患者眼动脉的血流速率。
Invest Ophthalmol Vis Sci. 2020 Oct 1;61(12):17. doi: 10.1167/iovs.61.12.17.
2
Short-term effect of latanoprost on ocular circulation in ocular hypertension.拉坦前列素对高眼压症患者眼循环的短期影响。
Clin Exp Ophthalmol. 2004 Aug;32(4):373-7. doi: 10.1111/j.1442-9071.2004.00840.x.
3
Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.曲伏前列素、拉坦前列素和比马前列素对眼循环影响的比较:一项为期6个月的临床试验。
Acta Ophthalmol Scand. 2007 Dec;85(8):838-43. doi: 10.1111/j.1600-0420.2007.00960.x. Epub 2007 Aug 2.
4
[Randomized parallel group study of 0.0015% tafluprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension (comparison with 0.005% latanoprost ophthalmic solution)].0.0015%他氟前列素滴眼液治疗原发性开角型青光眼或高眼压症患者的随机平行组研究(与0.005%拉坦前列素滴眼液对比)
Zhonghua Yan Ke Za Zhi. 2015 Feb;51(2):95-102.
5
Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial.奈他舒地尔/拉坦前列素固定剂量复方制剂治疗高眼压:一项随机 3 期临床试验的 3 个月数据。
Am J Ophthalmol. 2019 Nov;207:248-257. doi: 10.1016/j.ajo.2019.06.016. Epub 2019 Jun 21.
6
The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow.拉坦前列素对眼压和搏动性眼血流的短期影响。
Acta Ophthalmol Scand. 2002 Feb;80(1):54-8. doi: 10.1034/j.1600-0420.2002.800111.x.
7
The effects of latanoprost and brimonidine on blood flow velocity of the retrobulbar vessels: a 3-month clinical trial.拉坦前列素和溴莫尼定对球后血管血流速度的影响:一项为期3个月的临床试验。
Acta Ophthalmol Scand. 2003 Apr;81(2):155-60. doi: 10.1034/j.1600-0420.2003.00049.x.
8
Latanoprost treatment differentially affects intraocular pressure readings obtained with three different tonometers.拉坦前列素治疗对三种不同眼压计测量的眼压读数有不同影响。
Acta Ophthalmol. 2019 Dec;97(8):e1112-e1115. doi: 10.1111/aos.14170. Epub 2019 Jun 11.
9
Short-term Efficacy and Safety of a Latanoprost/Carteolol Fixed Combination Switched From Concomitant Therapy to in Patients With Primary Open-angle Glaucoma or Ocular Hypertension.从联合治疗转换为原发性开角型青光眼或高眼压症患者的拉坦前列素/卡替洛尔固定组合的短期疗效和安全性。
J Glaucoma. 2018 Dec;27(12):1175-1180. doi: 10.1097/IJG.0000000000001091.
10
A Prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma.一项关于高眼压症或开角型青光眼单眼试验的前瞻性、随机、研究者设盲评估。
Ophthalmology. 2009 Jul;116(7):1237-42. doi: 10.1016/j.ophtha.2009.01.054.

引用本文的文献

1
Homer1 Protects against Retinal Ganglion Cell Pyroptosis by Inhibiting Endoplasmic Reticulum Stress-Associated TXNIP/NLRP3 Inflammasome Activation after Middle Cerebral Artery Occlusion-Induced Retinal Ischemia. Homer1 通过抑制脑缺血后视网膜缺血诱导的内质网应激相关 TXNIP/NLRP3 炎性小体激活来保护视网膜神经节细胞发生细胞焦亡。
Int J Mol Sci. 2023 Nov 27;24(23):16811. doi: 10.3390/ijms242316811.
2
Measurement of Retrobulbar Blood Flow and Vascular Reactivity-Relevance for Ocular and Cardiovascular Diseases.球后血流和血管反应性的测量——对眼部和心血管疾病的相关性
Diagnostics (Basel). 2023 Nov 23;13(23):3514. doi: 10.3390/diagnostics13233514.
3
Change of Retinal Vessel Density After Lowering Intraocular Pressure in Ocular Hypertension.高眼压症患者降低眼压后视网膜血管密度的变化
Front Med (Lausanne). 2021 Dec 9;8:730327. doi: 10.3389/fmed.2021.730327. eCollection 2021.

本文引用的文献

1
Ocular blood flow as a clinical observation: Value, limitations and data analysis.作为一种临床观察指标的眼血流:价值、局限性及数据分析。
Prog Retin Eye Res. 2020 Jan 24:100841. doi: 10.1016/j.preteyeres.2020.100841.
2
Investigation of cerebrospinal fluid flow in the cerebral aqueduct using high-resolution phase contrast measurements at 7T MRI.使用7T磁共振成像的高分辨率相位对比测量技术对中脑导水管内脑脊液流动进行研究。
Acta Radiol. 2018 Aug;59(8):988-996. doi: 10.1177/0284185117740762. Epub 2017 Nov 15.
3
Corneal Biomechanical Changes After Trabeculectomy and the Impact on Intraocular Pressure Measurement.小梁切除术后角膜生物力学变化及其对眼压测量的影响。
J Glaucoma. 2017 Mar;26(3):278-282. doi: 10.1097/IJG.0000000000000595.
4
The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma.原发性开角型青光眼患者长期使用前列腺素类似物对角膜生物力学特性的影响。
Br J Ophthalmol. 2017 Feb;101(2):120-125. doi: 10.1136/bjophthalmol-2016-308432. Epub 2016 May 9.
5
Changes in Axial Length and Refractive Error After Noninvasive Normalization of Intraocular Pressure From Elevated Levels.眼压从升高水平无创恢复正常后眼轴长度和屈光不正的变化。
Am J Ophthalmol. 2016 Mar;163:132-139.e2. doi: 10.1016/j.ajo.2015.12.004. Epub 2015 Dec 14.
6
Anatomy of the Ophthalmic Artery: A Review concerning Its Modern Surgical and Clinical Applications.眼动脉的解剖:关于其现代外科手术及临床应用的综述
Anat Res Int. 2015;2015:591961. doi: 10.1155/2015/591961. Epub 2015 Nov 9.
7
Ocular Blood Flow Autoregulation Mechanisms and Methods.眼部血流自动调节机制与方法。
J Ophthalmol. 2015;2015:864871. doi: 10.1155/2015/864871. Epub 2015 Oct 21.
8
Effect of topical prostaglandin analogues on corneal hysteresis.局部用前列腺素类似物对角膜滞后的影响。
Acta Ophthalmol. 2015 Sep;93(6):e495-8. doi: 10.1111/aos.12689. Epub 2015 Feb 26.
9
Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.全球青光眼患病率及 2040 年青光眼负担预测:系统评价和荟萃分析。
Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013. Epub 2014 Jun 26.
10
The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes.前列腺素类似物对开角型青光眼患者角膜生物力学特性及中央厚度的影响:一项针对108只眼的3年研究。
Drug Des Devel Ther. 2013 Oct 4;7:1149-56. doi: 10.2147/DDDT.S50622. eCollection 2013.

眼压降低不会影响高眼压症患者眼动脉的血流速率。

Intraocular Pressure Decrease Does Not Affect Blood Flow Rate of Ophthalmic Artery in Ocular Hypertension.

机构信息

Department of Clinical Sciences, Ophthalmology, Umeå University, Umeå, Sweden.

Wallenberg Center for Molecular Medicine, Umeå University, Umeå, Sweden.

出版信息

Invest Ophthalmol Vis Sci. 2020 Oct 1;61(12):17. doi: 10.1167/iovs.61.12.17.

DOI:10.1167/iovs.61.12.17
PMID:33074299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7585392/
Abstract

PURPOSE

To investigate if decrease of IOP affects the volumetric blood flow rate in the ophthalmic artery (OA) in patients with previously untreated ocular hypertension.

METHODS

Subjects with untreated ocular hypertension (n = 30; mean age 67 ± 8 years; 14 females) underwent ophthalmologic examination and a 3-Tesla magnetic resonance imaging investigation. The magnetic resonance imaging included three-dimensional high-resolution phase-contrast magnetic resonance imaging to measure the OA blood flow rate. The subjects received latanoprost once daily in the eye with higher pressure, the untreated eye served as control. The same measurements were repeated approximately 1 week later.

RESULTS

The mean OA blood flow rate before and after treatment was 12.4 ± 4.4 and 12.4 ± 4.6 mL/min in the treated eye (mean ± SD; P = 0.92) and 13.5 ± 5.2 and 13.4 ± 4.1 mL/min in the control eye (P = 0.92). There was no significant difference between the treated and control eye regarding blood flow rate before (P = 0.13) or after treatment (P = 0.18), or change in blood flow rate after treatment (0.1 ± 3.1 vs. -0.1 ± 4.0 mL/min, P = 0.84). Latanoprost decreased the IOP by 7.2 ± 3.1 mm Hg in the treated eye (P < 0.01).

CONCLUSIONS

The results indicate that a significant lowering of IOP does not affect the blood flow rate of the OA in ocular hypertension subjects. The ability to maintain blood supply to the eye independent of the IOP could be a protective mechanism in preserving vision in subjects with ocular hypertension.

摘要

目的

探讨未经治疗的高眼压患者眼压降低是否会影响眼动脉(OA)的容积血流速率。

方法

未经治疗的高眼压患者(n=30;平均年龄 67±8 岁;女性 14 名)接受眼科检查和 3T 磁共振成像检查。磁共振成像包括三维高分辨率相位对比磁共振成像,以测量 OA 血流速率。在眼压较高的眼滴用拉坦前列素,未治疗的眼作为对照。大约 1 周后重复相同的测量。

结果

治疗前和治疗后 OA 的平均血流速率分别为治疗眼 12.4±4.4 和 12.4±4.6mL/min(均值±标准差;P=0.92),和对照眼 13.5±5.2 和 13.4±4.1mL/min(P=0.92)。治疗眼和对照眼之间在血流速率方面,治疗前(P=0.13)和治疗后(P=0.18),或治疗后血流速率的变化(0.1±3.1 与-0.1±4.0mL/min,P=0.84)均无显著差异。拉坦前列素使治疗眼的眼压降低了 7.2±3.1mmHg(P<0.01)。

结论

结果表明,眼压的显著降低不会影响高眼压患者 OA 的血流速率。这种能够独立于眼压维持眼睛供血的能力可能是保护高眼压患者视力的一种保护机制。